RecruitingNCT04840056

Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic Gastritis

Prediction of Gastric Cancer in Intestinal Metaplasia and Atrophic Gastritis - Application of Artificial Intelligence in Histology and Clinical Data


Sponsor

Chinese University of Hong Kong

Enrollment

1,300 participants

Start Date

Apr 15, 2021

Study Type

OBSERVATIONAL

Conditions

Summary

The primary objectives of this study are: * To identify clinical or histological factors associated with gastric cancer development in patients with IM and AG * To establish a machine learning algorithm for prediction of future gastric cancer risks and individual risk stratification in patient with IM and AG


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is following people with early precancerous changes in the stomach lining — called atrophic gastritis or intestinal metaplasia — to learn more about who goes on to develop stomach cancer over time. These conditions are relatively common, especially in older adults, and can be detected on routine upper endoscopy. By tracking a large group of patients over time, researchers hope to identify which factors predict cancer development and to build better screening and early detection tools. **You may be eligible if:** - You are 18 years of age or older - You have been diagnosed (confirmed by tissue sample during a scope procedure) with atrophic gastritis or intestinal metaplasia in your stomach **You may NOT be eligible if:** - There are no listed exclusion criteria for this study — it appears this study is broadly open to anyone meeting the above criteria Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Prince of Wales Hospital

Shatin, New Territories, Hong Kong

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04840056


Related Trials